VIC Technology Venture Development
VIC Technology Venture Development, LLC is a venture capital firm established in 2000 and located in Fayetteville, Arkansas, with additional offices across North America. The firm specializes in seed, startup, and early-stage investments, focusing primarily on technology solutions and healthcare-related innovations. It identifies and commercializes technologies sourced from leading universities worldwide, employing a rigorous vetting process to select high-potential opportunities with significant societal impacts. VIC Technology Venture Development typically invests between $0.25 million and $0.5 million in its portfolio companies, which span various sectors, including medical devices, therapeutics, diagnostics, clean water, animal health, food safety, and automotive safety. The firm actively participates in the management of its investments, often taking board positions to ensure effective governance and strategic development.
Developer of therapeutic peptides designed to significantly reduce brain damage from stroke. The company's platform provides an optimized peptide with demonstrated efficacy consisting of two functional domains for the drug to cross the blood-brain barrier, enabling patients to get a neuroprotective option for stroke that would lessen brain damage and long-term health impacts.
Solenic Medical, Inc. is a medical device company founded in 2019 and based in College Station, Texas. It specializes in developing a non-invasive treatment for infected metallic implants using a technology that employs alternating magnetic fields generated by external coils. This innovative approach targets biofilm on the surfaces of medical implants, which is a significant complication in surgeries like knee and hip replacements, as well as in trauma-related procedures involving plates and rods. The technology has the potential to replace the costly and risky two-step revision surgical procedure currently used to address chronic infections in medical implants, thereby offering a safer and more effective solution for patients.
Filtravate is a membrane technology company that develops ultrafiltration membranes for applications in the bioprocessing and biopharmaceutical industries. Filtravate’s membranes have controlled and tunable pore size, even pore distribution, and functionalized surfaces. Based on patent-pending technology licensed from New Mexico State University (NMSU), Filtravate’s products provide significant anti-fouling and improved flux characteristics.
Solenic Medical, Inc. is a medical device company founded in 2019 and based in College Station, Texas. It specializes in developing a non-invasive treatment for infected metallic implants using a technology that employs alternating magnetic fields generated by external coils. This innovative approach targets biofilm on the surfaces of medical implants, which is a significant complication in surgeries like knee and hip replacements, as well as in trauma-related procedures involving plates and rods. The technology has the potential to replace the costly and risky two-step revision surgical procedure currently used to address chronic infections in medical implants, thereby offering a safer and more effective solution for patients.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.